US Broker Ratings

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

HealthEquity, Inc. (HQY) Stock Analysis: Robust Growth Potential with 36.98% Upside

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the healthcare information services industry, is grabbing the attention of savvy investors with its significant growth potential and robust market positioning. With..

Alkermes plc (ALKS) Stock Analysis: Exploring a 33% Upside Potential Amidst Diverse Product Portfolio

Alkermes plc (NASDAQ: ALKS) is capturing investor attention with its potential upside of 33.40%, as indicated by its average target price of $44.53. This Ireland-based biopharmaceutical company operates in the..

AbbVie Inc. (ABBV): Investor Outlook with 21% Potential Upside and Strong Buy Ratings

Investors with an eye on the healthcare sector may find AbbVie Inc. (NYSE: ABBV) an enticing opportunity. With a market capitalization of $365.43 billion, this U.S.-based biopharmaceutical giant remains a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a Potential 68% Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its promising advancements in treating rare neuroendocrine diseases. With a current market capitalization of $5.61 billion, Rhythm..

Corcept Therapeutics Inc. (CORT) Stock Analysis: A 36.91% Upside Potential in Biotech

For investors with a keen interest in the biotechnology sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing prospect. With a market capitalization of $5.52 billion, this Redwood City, California-based..

ADMA Biologics Inc (ADMA) Investor Outlook: Potential 96% Upside Sparks Interest

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the healthcare sector, operates within the biotechnology industry, specializing in the development and commercialization of plasma-derived biologics. Headquartered in Ramsey, New..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 21% Potential Upside Opportunity

AstraZeneca PLC (AZN), a leading player in the biopharmaceutical sector, continues to capture investor attention with its robust market presence and a significant potential upside. This UK-based healthcare giant, with..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring a Potential 26.58% Upside

Cardinal Health, Inc. (NYSE: CAH) is a heavyweight in the healthcare sector, specializing in medical distribution—a critical industry that ensures the smooth delivery of healthcare products across the United States..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with 11.74% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors. With a market..

Masimo Corporation (MASI) Stock Analysis: Navigating Steady Growth with a Modest Upside

Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices sector, continues to attract attention with its innovative patient monitoring technologies. Headquartered in Irvine, California, Masimo has carved a..

UnitedHealth Group (UNH) Stock Analysis: Navigating Healthcare with a 5.01% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector with a substantial market capitalization of $334.93 billion, remains a formidable player in the healthcare plans industry. With its..

Guardant Health, Inc. (GH)

⚠️ No article content returned.

..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Uncovering a 34% Potential Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is a name that should capture investor attention, not only for its innovative contributions to the biotechnology field but also for its compelling potential upside..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth Amid Challenging Metrics

Oscar Health, Inc. (NYSE: OSCR) is making waves in the healthcare sector with its innovative approach to health plans and technology-driven services. With a market capitalization of $5.57 billion, the..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring a 31% Upside Potential in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (MDGL), a key player in the biotech sector, presents a compelling opportunity for investors seeking exposure to cutting-edge therapeutics in the healthcare industry. With a market cap..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Is a 52.44% Upside Just Around the Corner?

iRhythm Holdings, Inc. (NASDAQ: IRTC) has captured the attention of the healthcare investment community with its innovative approach to cardiac monitoring technology. As a leader in the medical devices industry,..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Biotech’s Challenges with 260% Revenue Growth

Moderna, Inc. (NASDAQ: MRNA) has firmly established itself as a pivotal player in the biotechnology sector, particularly in the realm of mRNA-based therapeutics. With a market capitalization of $17.99 billion,..

Ascendis Pharma A/S (ASND) Stock Analysis: A 34% Potential Upside Beckons Investors

In the dynamic world of biotechnology, Ascendis Pharma A/S (NASDAQ: ASND) is gaining attention with a promising 34.45% potential upside, according to analyst ratings. As a biopharmaceutical company headquartered in..

Inspire Medical Systems, Inc. (INSP) Investor Outlook: A Healthcare Innovator with a 27% Upside Potential

For investors seeking exposure to the healthcare sector, Inspire Medical Systems, Inc. (NYSE: INSP) presents a compelling opportunity. Specializing in innovative medical devices for treating obstructive sleep apnea (OSA), Inspire..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds